This on-demand webinar was recorded on November 15, 2017
Clavicle fractures are among the most common injuries treated by orthopaedists. Until 2005, no matter the amount of displacement, their treatment was rather standard – immobilize for a few weeks, and then gradually increase activity until the fracture healed. In 2007 Dr. Mike McKee published a landmark article in JBJS that concluded that clavicle fractures with displacement greater than 100% had better outcomes if treated with open reduction and internal fixation (ORIF).
Since that time, numerous studies have re-examined this conclusion, some supporting its findings, and some disputing them. On November 15, 2017 at 7 PM EDT, JBJS will join with JSES (Journal of Shoulder and Elbow Surgery) to present a webinar looking at the current paradigm for treatment of clavicle fractures.
The webinar will be moderated by Dr. William Mallon, editor-in-chief of JSES.
The webinar will focus on two recent clavicle-fracture papers.
• Dr. Philip Ahrens will discuss his very recent JBJS paper, “The Clavicle Trial: A Multicenter Randomized Controlled Trial Comparing Operative with Nonoperative Treatment of Displaced Midshaft Clavicle Fractures.”
• Dr. Brian Feeley will discuss his 2016 JSES paper, “Plate Fixation of Midshaft Clavicular Fractures: Patient-Reported Outcomes and Hardware-Related Complications.”
After each paper, expert commentary will be provided. Discussing Dr. Ahrens’ paper will be Dr. Michael McKee, recently named chairman of orthopaedics at the University of Arizona. Dr. Gus Mazzocca, chairman of orthopaedics at the University of Connecticut, will comment on Dr. Feeley’s paper. The webinar will then be open to addressing viewer-submitted questions for the authors and the commentators.
A live Q&A session follows the presentations and provides the audience with the opportunity to further explore the concepts and data presented.
Presented: November 15, 2017
Moderated by Dr. William Mallon
Authors: Dr. Philip Ahrens, Dr. Brian Feeley
Commentators: Dr. Michael McKee, Dr. Gus Mazzocca